Menu
Back to Journals » Drug Design, Development and Therapy » Volume 14
Hypothesis
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,304 | Dovepress* | 7,194+ | 1,344 | 8,538 | |
| PubMed Central* | 1,110 | 248 | 1,358 | ||
| Totals | 8,304 | 1,592 | 9,896 | ||
| *Since 6 July 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 0 | 8 |
View citations on PubMed Central and Google Scholar